PapersFlow Research Brief
Helicobacter pylori-related gastroenterology studies
Research Guide
What is Helicobacter pylori-related gastroenterology studies?
Helicobacter pylori-related gastroenterology studies are a body of medical research that investigates how Helicobacter pylori infection causes and modifies gastric mucosal disease—especially gastritis and gastric adenocarcinoma—and how diagnosis, risk stratification, and eradication strategies can prevent downstream malignancy.
This literature cluster comprises 151,321 works focused on Helicobacter pylori pathogenesis, gastric mucosal phenotypes (e.g., atrophy and intestinal metaplasia), and gastric cancer risk, alongside management topics such as antibiotic resistance and eradication therapy. "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001) explicitly links infection status and histologic mucosal patterns (severe gastric atrophy, corpus-predominant gastritis, intestinal metaplasia) to subsequent gastric cancer risk. Foundational clinical-pathology frameworks such as "Classification and Grading of Gastritis" (1996) provide standardized descriptors that enable reproducible phenotyping in H. pylori-associated disease and cancer-risk studies.
Topic Hierarchy
Research Sub-Topics
Helicobacter pylori Pathogenesis
Researchers study bacterial virulence factors including CagA, VacA, and adhesins driving gastric mucosal damage. Molecular pathogenesis models link host-pathogen interactions to epithelial cell signaling and immune evasion.
H. pylori Antibiotic Resistance
This sub-topic examines resistance mechanisms to clarithromycin, metronidazole, and levofloxacin in clinical isolates. Genomic surveillance and phenotypic testing guide personalized eradication regimens.
H. pylori Eradication Therapy
Studies compare quadruple therapies, vonoprazan-based regimens, and probiotics as adjuncts for eradication success. Meta-analyses assess post-eradication gastric cancer risk reduction and recurrence prevention.
H. pylori and Gastric Cancer Risk
Epidemiological research quantifies infection-attributable cancer fractions and interactions with dietary carcinogens. Cohort studies track atrophy-metaplasia-carcinoma sequences post-infection.
Host Genetic Susceptibility to H. pylori
Investigators identify polymorphisms in IL-1β, TNF-α, and TLR genes modulating infection outcomes and cancer risk. Genome-wide association studies reveal hypochlorhydria-promoting variants.
Why It Matters
H. pylori-related gastroenterology studies matter because they define actionable pathways for gastric cancer prevention by identifying who is at risk, what mucosal changes signal progression, and when eradication or surveillance is clinically justified. Prospective clinical evidence directly tying infection to cancer underpins prevention-oriented care: Uemura et al. (2001) reported that gastric cancer develops in persons infected with H. pylori but not in uninfected persons, and further identified severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia as higher-risk histologic settings ("Helicobacter pylori Infection and the Development of Gastric Cancer" (2001)). Earlier epidemiologic evidence that infection is associated with increased risk of gastric adenocarcinoma was articulated by Parsonnet et al. (1991) in "Helicobacter pylori Infection and the Risk of Gastric Carcinoma" (1991), which supports the clinical rationale for testing-and-treating strategies in appropriate populations. In practice, these studies connect histopathology (standardized by Dixon et al. (1996) in "Classification and Grading of Gastritis" (1996)) to prevention decisions, enabling clinicians and researchers to align biopsy interpretation, risk stratification, and follow-up for patients with H. pylori-associated mucosal disease.
Reading Guide
Where to Start
Start with Dixon et al. (1996), "Classification and Grading of Gastritis" (1996), because it provides the shared diagnostic language (topography, morphology, etiology) that later H. pylori and cancer-risk studies rely on for comparable phenotyping.
Key Papers Explained
A practical reading sequence links pathology standardization to cancer-risk evidence and then to mechanism. Dixon et al. (1996) in "Classification and Grading of Gastritis" (1996) establishes reproducible gastritis descriptors; Parsonnet et al. (1991) in "Helicobacter pylori Infection and the Risk of Gastric Carcinoma" (1991) frames infection as a risk factor for gastric adenocarcinoma; Uemura et al. (2001) in "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001) ties infection plus specific histologic contexts (atrophy, corpus-predominant gastritis, intestinal metaplasia) to cancer development; Tomb et al. (1997) in "The complete genome sequence of the gastric pathogen Helicobacter pylori" (1997) provides the genomic basis for mechanistic virulence hypotheses; Smyth et al. (2020) in "Gastric cancer" (2020) situates H. pylori-driven carcinogenesis within the broader clinical management and research questions of gastric malignancy.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Advanced work commonly triangulates three layers: (1) standardized mucosal phenotyping ("Classification and Grading of Gastritis" (1996)); (2) infection-to-cancer natural history ("Helicobacter pylori Infection and the Risk of Gastric Carcinoma" (1991); "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001)); and (3) mechanistic host–microbe frameworks leveraging microbial community concepts ("Diversity of the Human Intestinal Microbial Flora" (2005); "Gut Microbiota in Health and Disease" (2010); "The gut microbiota — masters of host development and physiology" (2013)) and pathogen genomics ("The complete genome sequence of the gastric pathogen Helicobacter pylori" (1997)). A key frontier is translating these links into clinically usable risk models that align histology-defined states (atrophy, intestinal metaplasia) with prevention strategies discussed in "Gastric cancer" (2020).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Diversity of the Human Intestinal Microbial Flora | 2005 | Science | 7.7K | ✓ |
| 2 | Association of NOD2 leucine-rich repeat variants with suscepti... | 2001 | Nature | 5.6K | ✕ |
| 3 | Classification and Grading of Gastritis | 1996 | The American Journal o... | 5.1K | ✕ |
| 4 | Gastric cancer | 2020 | The Lancet | 4.5K | ✕ |
| 5 | <i>Helicobacter pylori</i> Infection and the Development of Ga... | 2001 | New England Journal of... | 4.4K | ✓ |
| 6 | Gut Microbiota in Health and Disease | 2010 | Physiological Reviews | 4.0K | ✕ |
| 7 | <i>Helicobacter pylori</i> Infection and the Risk of Gastric C... | 1991 | New England Journal of... | 3.9K | ✓ |
| 8 | Intestinal mucosal barrier function in health and disease | 2009 | Nature reviews. Immuno... | 3.6K | ✕ |
| 9 | The gut microbiota — masters of host development and physiology | 2013 | Nature Reviews Microbi... | 3.6K | ✕ |
| 10 | The complete genome sequence of the gastric pathogen Helicobac... | 1997 | Nature | 3.5K | ✓ |
In the News
CURE-H. Pylori: A Trial on the Combination of Anti- ...
ClinicalTrials.gov Hide glossary#### Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms
The Helicobacter pylori AI-clinician harnesses artificial intelligence to personalise H. pylori treatment recommendations
The European Registry on _Helicobacter pylori_ management (Hp-EuReg) was established to combat the high social and health burden of _H. pylori_ infection across Europe. It was noted at the time tha...
Helicobacter pylori, microbiota and gastric cancer — principles of microorganism-driven carcinogenesis
association with gastric cancer and ulcer disease. Ulcers 2011, 1–23 (2011). Article
Meta-analysis of H. pylori and the gut microbiome interactions ...
Front Cell Infect Microbiol . 2025 Aug 1;15:1610523. doi: 10.3389/fcimb.2025.1610523 # Meta-analysis of _H. pylori_ and the gut microbiome interactions and clinical outcomes Xiongjian Wu ###...
Fecal microbiota transplantation emerges as a promising ...
Source: Journal reference:
Code & Tools
This repository presents a research project aimed at identifying novel drug targets in **multidrug-resistant _Helicobacter pylori_** using **in sil...
This project endeavours to delve into the comparative genomics of Helicobacter pylori (H. pylori) isolates from diverse human populations. By emplo...
This repository presents two distinct methodologies for the detection of Helicobacter pylori (H. pylori) infections within histological images with...
## About
## Repository files navigation ## Hepatitis IG This is the implementation guide (draft) for the national hepatitis program of the Philippines. #...
Recent Preprints
Effects of Helicobacter pylori infection on gastric cancer, obesity and esophageal diseases: a systematic review and meta-analysis
Effects of*Helicobacter pylori*infection on gastric cancer, obesity and esophageal diseases: a systematic review and meta-analysis Download PDF * Qian Zhou 1 , * Ruohan Yan 1 , 2 , * Xiaomin Wu 1...
Burden of gastric cancer attributable to Helicobacter pylori in 27 countries from seven geographic regions in 2022
This study provides estimates of the burden of GC attributable to*H. pylori*infection in 27 countries from seven geographic regions in 2022. Population attributable fractions are based on country-s...
Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II | Gut
Gut 2025; 74: 1767-1791. Publication history Received June 2, 2025 Accepted July 1, 2025 First published September 5, 2025. Request permissions
Systemic Impact of Helicobacter pylori: A Cross‐Sectional Study
*Helicobacter pylori*is an oncobacteria that infects about half of the world's population and has a well‐established role in the etiology of gastric diseases. Lately, this infection has also been a...
Prevalence of Helicobacter pylori infection and gastric ...
Conclusions This study is the first large Greek study to estimate the histopathological prevalence of H. pylori infection and GIM in a population from a primary care gastrointestinal unit. There ...
Latest Developments
Recent developments in Helicobacter pylori-related gastroenterology research include updated treatment guidelines recommending non-clarithromycin-based regimens with success rates exceeding 90% ((UIC), (LWW)) and new therapies such as tegoprazan-based triple therapy showing promising results in clinical trials (PubMed). Additionally, research indicates that Helicobacter pylori genome evolution occurs during disease progression, and eradication efforts are associated with reduced gastric cancer risk (Nature, Biomed Central) as of early 2026.
Sources
Frequently Asked Questions
What is the strongest clinical evidence that Helicobacter pylori infection is linked to gastric cancer development?
Uemura et al. (2001) concluded that gastric cancer develops in persons infected with H. pylori but not in uninfected persons in "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001). Parsonnet et al. (1991) also reported an association between H. pylori infection and increased risk of gastric adenocarcinoma in "Helicobacter pylori Infection and the Risk of Gastric Carcinoma" (1991).
How do researchers standardize and compare gastritis findings across H. pylori studies?
Dixon et al. (1996) described the Sydney System approach of combining topographical, morphological, and etiological information to generate reproducible diagnoses in "Classification and Grading of Gastritis" (1996). This standardization supports consistent reporting of H. pylori-associated patterns used in cancer-risk analyses.
Which gastric histology patterns are repeatedly highlighted as higher-risk contexts in H. pylori infection?
Uemura et al. (2001) identified severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia as settings associated with increased gastric cancer risk in "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001). The implication is that studies and clinics can use these phenotypes for risk stratification once H. pylori infection is documented.
Which foundational genomic resource supports mechanistic research on H. pylori virulence and host interaction?
"The complete genome sequence of the gastric pathogen Helicobacter pylori" (1997) provides a reference genome resource for studying bacterial factors involved in colonization and disease. Such genomic grounding is commonly used to frame mechanistic hypotheses in H. pylori-related gastroenterology studies.
How does broader gut microbiome research inform interpretation of H. pylori-related gastric disease studies?
Eckburg et al. (2005) characterized intestinal microbial diversity using 13,355 prokaryotic ribosomal RNA gene sequences in "Diversity of the Human Intestinal Microbial Flora" (2005), establishing methods and concepts for microbial community description. Reviews such as "Gut Microbiota in Health and Disease" (2010) and "The gut microbiota — masters of host development and physiology" (2013) provide general frameworks for host–microbe interactions that are often invoked when considering how microbial ecology may modulate mucosal inflammation and disease phenotypes.
Which paper provides a high-level clinical context for gastric cancer relevant to H. pylori-focused prevention research?
"Gastric cancer" (2020) synthesizes clinical knowledge about gastric cancer and is frequently used to contextualize prevention and early-detection strategies in H. pylori research. It complements infection-specific evidence such as Parsonnet et al. (1991) and Uemura et al. (2001) by situating H. pylori within the broader clinical management of gastric malignancy.
Open Research Questions
- ? How can standardized gastritis grading in "Classification and Grading of Gastritis" (1996) be operationalized to prospectively predict which H. pylori-infected patients will progress to cancer as described in "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001)?
- ? Which bacterial genomic features enabled by "The complete genome sequence of the gastric pathogen Helicobacter pylori" (1997) best explain why only a subset of infected individuals develop the high-risk histologic patterns highlighted by Uemura et al. (2001) in "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001)?
- ? How should models of host–microbiota interaction from "Diversity of the Human Intestinal Microbial Flora" (2005), "Gut Microbiota in Health and Disease" (2010), and "The gut microbiota — masters of host development and physiology" (2013) be adapted to gastric (not intestinal) ecosystems to explain variability in inflammation and carcinogenesis risk among H. pylori-infected patients?
- ? Which mucosal barrier mechanisms summarized in "Intestinal mucosal barrier function in health and disease" (2009) are most relevant to translating H. pylori-associated gastritis phenotypes into measurable biomarkers of progression toward gastric cancer?
- ? How can clinical synthesis in "Gastric cancer" (2020) be integrated with infection-specific risk evidence from "Helicobacter pylori Infection and the Risk of Gastric Carcinoma" (1991) and "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001) to define evidence-based thresholds for surveillance in patients with atrophy or intestinal metaplasia?
Recent Trends
Across 151,321 works in this cluster, highly cited foundations continue to anchor newer H. pylori studies: infection-to-cancer association evidence (Parsonnet et al. , "Helicobacter pylori Infection and the Risk of Gastric Carcinoma" (1991)) and histology-mediated risk stratification (Uemura et al. (2001), "Helicobacter pylori Infection and the Development of Gastric Cancer" (2001)) remain central, while standardized reporting of gastritis phenotypes (Dixon et al. (1996), "Classification and Grading of Gastritis" (1996)) supports comparability across cohorts.
1991Mechanistic interpretation increasingly borrows general host–microbiota concepts from Eckburg et al. , "Diversity of the Human Intestinal Microbial Flora" (2005), and synthesis reviews such as "Gut Microbiota in Health and Disease" (2010) and "The gut microbiota — masters of host development and physiology" (2013), alongside pathogen biology grounded in "The complete genome sequence of the gastric pathogen Helicobacter pylori" (1997).
2005Clinical framing for how H. pylori prevention fits into gastric oncology is commonly contextualized using "Gastric cancer" .
2020Research Helicobacter pylori-related gastroenterology studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Helicobacter pylori-related gastroenterology studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers